USPSTF recommends against ovarian cancer screening

February 13, 2018

(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends against screening for ovarian cancer in asymptomatic women. These findings form the basis of a final recommendation statement published in the Feb. 13 issue of the Journal of the American Medical Association.

To update the 2012 USPSTF recommendation, researchers reviewed the evidence on the benefits and harms of screening for ovarian among not known to be at high risk for ovarian cancer. Data were reviewed from four trials with 293,587 participants. Three studies assessed ovarian cancer mortality, while one reported only on psychological outcomes.

The researchers found that there was adequate evidence that ovarian cancer screening does not reduce ovarian cancer mortality. Adequate evidence was also found suggesting that the harms of screening may be substantial in some cases, including unnecessary surgery in women without cancer. Based on these findings, the USPSTF concludes with moderate certainty that the harms of ovarian cancer screening outweigh the potential benefits.

"The Task Force recommends against screening for ovarian cancer in women who have no signs or symptoms," Task Force member Michael J. Barry, M.D., said in a statement. "Evidence shows that current screening methods do not prevent women from dying of and that screening can lead to unnecessary surgery in women without cancer."

Explore further: USPSTF: Ovarian cancer screen to be avoided for most women

More information: Evidence Report
Final Recommendation Statement
Editorial

Related Stories

USPSTF: Ovarian cancer screen to be avoided for most women

July 20, 2017
(HealthDay)—The potential harms of ovarian cancer screening outweigh the benefits, so only very specific groups of women should be screened for the disease, the U.S. Preventive Services Task Force (USPSTF) says in a draft ...

USPSTF reviews use of ECG for preventing A-fib, CVD events

December 19, 2017
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found that the current evidence is inadequate to assess the benefits and harms of screening with electrocardiogram (ECG) for atrial fibrillation (AF) in older ...

Screening for thyroid cancer not recommended

May 9, 2017
The U.S. Preventive Services Task Force (USPSTF) recommends against screening for thyroid cancer in adults without any signs or symptoms. The report appears in the May 9 issue of JAMA.

Ovarian CA screening potentially cost-effective in the U.S.

December 8, 2017
(HealthDay)—Multimodal screening (MMS) for ovarian cancer is potentially cost-effective in the United States, according to a study published online Dec. 7 in JAMA Oncology.

Evidence insufficient regarding screening for gynecologic conditions with pelvic examination

March 7, 2017
The U.S. Preventive Services Task Force (USPSTF) has concluded that the current evidence is insufficient to assess the balance of benefits and harms of performing screening pelvic examinations in asymptomatic, nonpregnant ...

USPSTF: evidence lacking for pelvic screening examinations

June 29, 2016
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has concluded that the current evidence is insufficient to weigh the balance of benefits and harms for screening pelvic examinations in asymptomatic, nonpregnant ...

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.